These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17066400)

  • 1. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
    Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
    Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossover trials with a cumulative response.
    Walter SD
    J Biopharm Stat; 1997 Nov; 7(4):649-66. PubMed ID: 9358336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2161-73. PubMed ID: 12210631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of incomplete data in the three-period two-treatment cross-over design for clinical trials.
    Richardson BA; Flack VF
    Stat Med; 1996 Jan; 15(2):127-43. PubMed ID: 8614750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses.
    Atkinson AC; Biswas A
    Stat Med; 2005 Aug; 24(16):2477-92. PubMed ID: 16007571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chop-lump tests for vaccine trials.
    Follmann D; Fay MP; Proschan M
    Biometrics; 2009 Sep; 65(3):885-93. PubMed ID: 19210727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate Mann-Whitney estimators for the comparison of two treatments in a three-period crossover study with randomly missing data.
    Kawaguchi A; Koch GG
    J Biopharm Stat; 2010 Jul; 20(4):720-44. PubMed ID: 20496202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysing non-compliance in clinical trials: ethical imperative or mission impossible?
    Goetghebeur EJ; Shapiro SH
    Stat Med; 1996 Dec; 15(24):2813-26. PubMed ID: 8981688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline information in structural failure time estimators for the effect of observed treatment compliance.
    Loeys T; Goetghebeur E
    Stat Med; 2002 May; 21(9):1173-88. PubMed ID: 12111873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
    Liu GF; Lu K; Mogg R; Mallick M; Mehrotra DV
    Stat Med; 2009 Sep; 28(20):2509-30. PubMed ID: 19610129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-parametric and non-parametric methods for clinical trials with incomplete data.
    O'Brien PC; Zhang D; Bailey KR
    Stat Med; 2005 Feb; 24(3):341-58. PubMed ID: 15547952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementary analysis of probabilities at the termination of a group sequential phase II trial.
    Liu A; Wu C; Yu KF; Gehan E
    Stat Med; 2005 Apr; 24(7):1009-27. PubMed ID: 15565737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective exclusion of treatment arms in multi-arm randomized clinical trials.
    Law MG; Emery S
    Stat Med; 2003 Jan; 22(1):19-30. PubMed ID: 12486749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusting for partially missing baseline measurements in randomized trials.
    White IR; Thompson SG
    Stat Med; 2005 Apr; 24(7):993-1007. PubMed ID: 15570623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.